Articles On Visioneering Technologies Inc (ASX:VTI)

Visioneering Technologies (ASX:VTI) has announced plans to delist from the Australian Securities Exchange (ASX), with a vote on the proposal scheduled for a special meeting of stockholders on 10 January 2025. The company's board believes th...

Opyl has partnered to form the ‘world’s first’ AI-driven biotech fund Visioneering sees a brighter future – elsewhere – but its shares tumble  Cyclopharm breathes easy after decent lung transplant trial results   Who needs fund managers t...

Visioneering Technologies (ASX:VTI) has become the latest to step down before the footlamps, announcing its voluntary delisting on Tuesday. The US-based eyecare company has offered Chess Depository Interests (CDIs) on the ASX for years w...

ASX to lift again today after a mixed session on Wall Street German shoe brand Birkenstock’s debut listing was disappointing Some caution needed in the quarters ahead, says expert   Aussie shares are poised to rise for the fifth day strai...

Benchmark index finishes higher on strong oil prices ASX Sectors led by oil-driven gains for Energy Fin Resources banks a banger to be Monday’s small cap legend   The ASX200 found some enthusiasm for living on Monday arvo, supported abl...

The tech sector had a down month in September The return of the IPO has been badly overstated We take a look at the ASX tech winners for the month   Sentiment towards growth stocks got another reality check in September as traders took a...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Visioneering Technologies (VTI) welcomes Dr Juan Carlos Aragón as its newest CEO and Executive Director Dr Aragón brings more than 30 years of experience, comprising senior leadership positions in the vision care industry Previously h...

The ASX is set to open lower as Wall Street slid on fresh growth concerns EU regulators gave a ruling on Meta ads Brent crude slipped 4%   The ASX is set to open lower on Wednesday, tracking the selloff in New York. At 8am AEDT, the ASX 2...

The ASX 200 Health Index (XHJ) is falling by 0.3% at the time of writing, compared to the broader index which is down by 0.37%. Visioneering Technologies (ASX:VTI) has enrolled the first patient in its landmark international clinical trial...

Tech stocks plunge on Wall Street Risk-off sentiment dominated the US stockmarket last week with another tech selloff on Friday. The Nasdaq composite index fell 2.72%, taking its loss for the week to over 6%. The other two major benchmarks...

According to the consulting firm Korn Ferry, the average tenure of an Australian CEO is now 6.9 years – and falling. So, announcing his resignation this week, Visioneering (ASX:VTI) founder and CEO Dr Stephen Snowdy can be satisfied that he...

In October, the Chinese government released its intellectual proprietary (IP) patents strategy paper, listing its main goals for the next five years. Part of that plan is to double the foreign “high value” patents from the current 40,000 to...

Visioneering Technologies (VTI) has unveiled an enhanced contact lens at the American Academy of Optometry annual meeting in Boston NaturalVue are multifocal one-day contact lenses with a TripleTear lubrication system and ultra-tapered edg...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The ASX 200 health stocks index (XHJ) rose by 0.44% this morning, compared to the broader index which climbed by 0.15%. In a major development, Chimeric Therapeutics (ASX:CHM) announced that it has received IND (investigational new drug) cl...

Wall Street mixed as iron ore plunged The US stock markets closed in mixed territories on choppy trading overnight, with some solid guidance lifting sentiment. The S&P 500 rose by 0.13%, Dow Jones fell by 0.19%, while the tech heavy Nas...

Sports and hospitality software provider MSL Solutions (ASX:MSL) leads the ASX tech stocks today, up 12.5% off the back of its June quarterly. The company basically helps stadium operators manage workforces and see analytics in real time an...

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

The ASX quarterly earnings season is in full full swing. With so many releases every day, it’s easy for investors to miss what’s been happening, let alone identify winners from the losers. Stockhead has summarised a list of 8 small caps tha...

A quick wrap of the ASX’s key winners and losers on Thursday, August 20. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 553 stocks rose, 765 declined and...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast. In this episode Tim chats with Dr Stephen Snowdy, CEO from Visioneeri...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   This week’s big themes The ca...

A quick wrap of the key winners and losers on Wednesday, April 29. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day.   WINNERS Code Name Price % Chg...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Asia is rising as a healthcare spender, matching incomes and the long-feared elderly population boom. The region is a major part of a surge in health spending that is expected over the next few years, as rising lifestyle illnesses and ages...

U.S.-based medical device company Visioneering Technologies (VTI) will raise $3 million through a private placement Funds will go towards marketing its contact lenses in the U.S. Additionally, the company will continue to pursue internatio...

Marketing services provider Salmat (ASX:SLM) is continuing its rapid selloff of businesses, this time striking a deal to offload its MicroSourcing (Managed Services) business for $100m. The deal comes a month after the $156m company reveale...

Cancer is a crowded market, pot has sleep and pain issues covered — or so they say — and companies dip in and out of respiratory diseases all the time. But there are a few ASX-listed stocks that are tackling health issues that still rate as...

Spies defecting, a foreign power secretly taking control of Australia via 5G, the stealthy infiltration of universities and CSIRO, a new arms race waged through cyber-warfare. This is not a John Le Carre novel, these are the headlines shapi...

Ever since the advent of TV, worried parents have cautioned their kids that too much time in front of John Logie Baird’s infernal device will make them go blind – a warning routinely shrugged off by the juvenile couch potatoes. It seems tha...

Australian Stock Market Australia is one of the healthy and strong economies across the globe. The country has three major stock exchanges, namely: the Asia-Pacific Stock Exchange, the Australian Securities Exchange Group and the National S...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Eye care company Visioneering Technologies (ASX: VTI) is celebrating this morning after an industry competitor received a key approval from the US Food and Drug Administration (FDA) for its CooperVision’s MiSight contact lens – the first ap...

When it comes to buying shares in US entities which list on the ASX, investors could be forgiven if they keep their hands firmly in their pockets. Accessing the US market can be tricky for local investors, which is why many opt for exchange...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Analysts and CEOs of  companies targeting vision loss say there’s market opportunities above US$10 billion ($14.89 billion) for the taking. We aren’t talking about the entire vision loss market here. That’s $US10 billion worth of treatments...

Visioneering Technologies Inc. (ASX: VTI) has entered into definitive agreement with Menicon Co. Ltd. The agreement was signed with NKL Contactlenzen B.V. – a wholly owned subsidiary of Menicon Co. Ltd. VTI to supply NaturalVue® MF contact...

On Stockhead today, the first jobs of five ASX CEOs, how to pick a ‘recession-proof’ stock, and has Samsung cracked the graphene battery code? But first, here’s what you need to know.   The day ahead Little in the way of data at home. The E...

In this week’s recap of substantial shareholders, IOOF and a UK hedge fund manager take a bet they’ll recoup their losses in Speedcast (ASX:SDA), Australian Ethical Investment buys a 16 per cent stake in Cogstate (ASX:CGS) and Taurus increa...

DroneShield (ASX:DRO) shares climbed as much as 12 per cent higher this morning after the company reported it made about $1.1m from selling drones. This is the third quarter in a row that DroneShield has increased its sales revenue. With go...

The healthcare sector might be in for some merger and acquisition action, as cashed-up companies in a low-growth economy look for ways to grow. Morgans health analyst Scott Power says low interest rates combined with low economic growth and...

In this week’s recap of substantial holders, Jamie Pherous bought a 5.3 per cent stake in State Gas for $4.9m, Lombard Odier bought more of Salt Lake Potash, and Regal sold out of Visioneering Technologies and increased its stake in Nickel...